The Impact of Prophylaxis on Outcome and Resource Utilization in Pneumocystis carinii Pneumonia
- 1 April 1995
- Vol. 107 (4) , 1018-1023
- https://doi.org/10.1378/chest.107.4.1018
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention and Treatment of Pneumocystis PneumoniaNew England Journal of Medicine, 1992
- A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Pneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With ZidovudineArchives of internal medicine (1960), 1992
- The Effects on Survival of Early Treatment of Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDSThe Lancet, 1991
- Aerosolized Pentamidine for Prophylaxis againstPneumocystis cariniiPneumoniaNew England Journal of Medicine, 1990
- The Case for Wider Use of Testing for HIV InfectionNew England Journal of Medicine, 1989
- Acquired Immunodeficiency Syndrome Associated With Intravenous-Drug Use — United States, 1988Published by American Medical Association (AMA) ,1989
- Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDSJAMA, 1988